- Home
- IMNN vs MITQ Comparison
IMNN vs MITQ Comparison
Compare IMNN & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- MITQ
- Stock Information
- Founded
- IMNN 1982
- MITQ N/A
- Country
- IMNN United States
- MITQ United States
- Employees
- IMNN N/A
- MITQ N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- MITQ Telecommunications Equipment
- Sector
- IMNN Health Care
- MITQ Telecommunications
- Exchange
- IMNN Nasdaq
- MITQ Nasdaq
- Market Cap
- IMNN 12.9M
- MITQ 13.4M
- IPO Year
- IMNN 1985
- MITQ 2021
- Fundamental
- Price
- IMNN $5.33
- MITQ N/A
- Analyst Decision
- IMNN Buy
- MITQ
- Analyst Count
- IMNN 2
- MITQ 0
- Target Price
- IMNN $182.61
- MITQ N/A
- AVG Volume (30 Days)
- IMNN 153.1K
- MITQ 675.3K
- Earning Date
- IMNN 11-06-2025
- MITQ 11-13-2025
- Dividend Yield
- IMNN N/A
- MITQ N/A
- EPS Growth
- IMNN N/A
- MITQ N/A
- EPS
- IMNN N/A
- MITQ N/A
- Revenue
- IMNN N/A
- MITQ $18,147,000.00
- Revenue This Year
- IMNN N/A
- MITQ N/A
- Revenue Next Year
- IMNN N/A
- MITQ N/A
- P/E Ratio
- IMNN N/A
- MITQ N/A
- Revenue Growth
- IMNN N/A
- MITQ N/A
- 52 Week Low
- IMNN $4.70
- MITQ $0.50
- 52 Week High
- IMNN $41.22
- MITQ $1.66
- Technical
- Relative Strength Index (RSI)
- IMNN 47.96
- MITQ 45.08
- Support Level
- IMNN $5.04
- MITQ $0.91
- Resistance Level
- IMNN $5.55
- MITQ $1.07
- Average True Range (ATR)
- IMNN 0.29
- MITQ 0.12
- MACD
- IMNN 0.04
- MITQ -0.04
- Stochastic Oscillator
- IMNN 70.94
- MITQ 6.85
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.